Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ResMed Inc. Common Stock (NY:RMD)

245.04 +1.95 (+0.80%)
Official Closing Price Updated: 7:00 PM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ResMed Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Why ResMed Stock Is Jumping Today
The medical device maker beat expectations with its latest quarterly results. 
Via The Motley Fool
ResMed Flexes Its Operating Muscle, Sends Shares Flying Above Their 200-Day Line
ResMed reported better-than-expected sales and adjusted earnings. 
Via Investor's Business Daily
AT&T To Rally Around 44%? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
Recap: ResMed Q2 Earnings
Via Benzinga
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2024
From ResMed Inc.
Via GlobeNewswire
ResMed's Earnings: A Preview
Via Benzinga
Why NYSE:RMD provides a good dividend, while having solid fundamentals.
Exploring RESMED INC (NYSE:RMD)'s dividend characteristics. 
Via Chartmill
If You Invested $100 In This Stock 15 Years Ago, You Would Have $900 Today
Via Benzinga
Earnings Scheduled For January 24, 2024
Companies Reporting Before The Bell • Freeport-McMoRan (NYSE:FCX) is estimated to report quarterly earnings at $0.22 per share on revenue of $5.86 billion. 
Via Benzinga
Demystifying ResMed: Insights From 5 Analyst Reviews
Via Benzinga
Uncovering Dividend Opportunities with NYSE:RMD.
Why RESMED INC (NYSE:RMD) qualifies as a good dividend investing stock. 
Via Chartmill
$1000 Invested In ResMed 15 Years Ago Would Be Worth This Much Today
Via Benzinga
3 Stocks to Buy to Benefit From the Booming Sleep Industry
It’s not easy to find sleep stocks to buy despite the fact the industry is booming these days from society's lack of rest and relaxation. 
Via InvestorPlace
FDA Identifies ResMed's Recall Of Certain Ventilator Device Masks With Magnets As Most Serious
ResMed (NYSE: RMD) recalls certain respiratory masks with magnets due to potential interference with medical devices. FDA Class I recall. 
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
HCA Healthcare Rallies: Weight-loss drugs really a big threat?
HCA Healthcare rebounds amid concerns about weight-loss drugs' impact. The healthcare giant's revenue growth hints at resilience despite sector challenges. 
Via MarketBeat
Topics ETFs
Top Picks 2024: ResMed
ResMed is the market leader in continuous positive airway pressure machines. ResMed has enjoyed a steadily growing market throughout its history, and investors have often paid sky-high valuations for... 
Via Talk Markets
ResMed to Report Second Quarter Fiscal 2024 Earnings on January 24, 2024
From ResMed Inc.
Via GlobeNewswire
(RMD) - Analyzing ResMed's Short Interest
Via Benzinga
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $17,000 Today
Via Benzinga
ResMed Announces Participation in the 42nd Annual J.P. Morgan Healthcare Conference
From ResMed Inc.
Via GlobeNewswire
ResMed Notifies Customers About Updated Instructions and Labeling for Masks with Magnets Due to Potential Interference with Certain Medical Devices
ResMed’s masks with magnets are safe when used in accordance with the updated Instructions for Use 
From ResMed Inc.
Via GlobeNewswire
ResMed Secures Significant Victory in Patent Fight Against New York University
From ResMed Inc.
Via GlobeNewswire
Why NYSE:RMD qualifies as a good dividend investing stock.
Is RESMED INC (NYSE:RMD) a Good Fit for Dividend Investing? 
Via Chartmill
Why the dividend investor may take a look at NYSE:RMD.
Analyzing RESMED INC (NYSE:RMD)'s Dividend Potential. 
Via Chartmill
Study Estimates a 23% Increase in COPD by 2050, Representing 600 Million Patients Globally
From ResMed Inc.
Via GlobeNewswire
Senator's Bearish Tesla Bet Under Scrutiny As He Buys Put Options Ahead Of Elon Musk-Led Company's Q3 Results That Set Stock Slide In Motion
Sen. Tommy Tuberville bought 3 tranches of put options to sell Tesla shares at $190 a day ahead of Q3 results that set in motion a stock slump. 
Via Benzinga
ResMed Adopts New Operating Model to Accelerate Long-term Growth
From ResMed Inc.
Via GlobeNewswire
2 Monster Stocks to Buy Without Any Hesitation
Down 33% and 44%, these two stocks look too good to pass up today. 
Via The Motley Fool
How Sleep Device Player ResMed Is Gaining Philips' Market Share In Flow Generator Market - Analysts Weigh In
Needham analyst Mike Matson reiterated a Buy rating on ResMed Inc. (NYSE: RMD)  
Via Benzinga
Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact?
Makers of devices to treat obesity-related conditions have struggled recently. Analysts say there's more to the story. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.